Serum Institute of India is seeking DCGI's approval to administer Covishield as a booster dose citing adequate stock and a demand for a booster shot.
In an application to the Drugs Controller General of India (DCGI), Prakash Kumar Singh, the Director, Government and Regulatory Affairs at Serum Institute of India (SII) cited that the UK's Medicines and Healthcare products Regulatory Agency has already approved the booster dose of AstraZeneca ChAdOx1 nCoV-19 vaccine.
#SII #SerumInstitute #Omicron #Covishield #DCGI #COVID19 #IndiaToday
Subscribe to India Today for NEW VIDEOS EVERY DAY and make sure to enable Push Notifications so you'll never miss a new video.
All you need to do is PRESS THE BELL ICON next to the Subscribe button!
India Today TV is India's leading English News Channel. India Today YouTube channel offers latest news videos on Politics, Business, Cricket, Bollywood, Lifestyle, Auto, Technology, Travel, Entertainment and a lot more.
Stay tuned for latest updates and in-depth analysis of news from India and around the world!
Follow us: Official website: [ Ссылка ]
Twitter: [ Ссылка ]
Facebook: [ Ссылка ]
Telegram: [ Ссылка ]
